Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review
Surgery Today · 2025
DOI: 10.1007/s00595-025-03087-x ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Surgery Today, 2025. Verfasst von Kotaro Sugawara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. mayotic…. Hauptthemen laut MEDLINE: Chemoradiotherapy, Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.
Abstract (Originalsprache)
Purpose
To investigate the long-term outcomes of patients with cStage IV esophageal squamous cell carcinoma (ESCC) treated with definitive chemoradiotherapy (dCRT) and the impacts of this treatment on inflammatory and nutrition markers.
Methods
The subjects of this study were 84 patients who underwent initial dCRT for cStage IV (cT4 and/or cM1 according to eighth UICC staging system) esophageal squamous cell carcinoma (ESCC). Survival outcomes were investigated according to treatment modalities. Various inflammatory and nutrition markers, such as the C-reactive protein (CRP)-to-albumin ratio (CAR) and the lymphocyte-to-CRP ratio (LCR), were evaluated.
Results
The 3-year overall survival (OS) rate of the 84 patients was 45.8%. Clinical complete response (CR) to dCRT was achieved in 30 patients (dCRT-CR group). Salvage surgery was performed for 35 patients and curative (R0) resection was achieved in 28 patients (surg-R0 group). Patients in the surg-R0 group exhibited comparable 3-year OS (60.7%) to patients in the dCRT-CR group (60.0%). CRP-derived markers (LCR and CAR) were significantly associated with the response to dCRT (both P < 0.01) and OS (both P < 0.01).
Conclusions
Definitive chemoradiotherapy is appropriate for patients with cStage IV ESCC. Curative salvage surgery provides survival benefits for the tumor entity. Pre-therapeutic CRP-derived markers are useful for predicting the response to dCRT and long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. mayotic@hotmail.com.
- Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
- Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Förderung
- The University of Tokyo
Zitieren
APA
Sugawara, K., Yagi, K., Yajima, S., Miwa, Y., Oya, S., Okamoto, A., Asaoka, R., Yamashita, H., & Baba, Y. (2025). Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review. Surgery Today. https://doi.org/10.1007/s00595-025-03087-x
Vancouver
Sugawara K, Yagi K, Yajima S, Miwa Y, Oya S, Okamoto A, et al. Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review. Surgery Today. 2025. doi:10.1007/s00595-025-03087-x
BibTeX
@article{Sugawara2025,
author = {Sugawara, Kotaro and Yagi, Koichi and Yajima, Shoh and Miwa, Yoshiyuki and Oya, Shuichiro and Okamoto, Asami and Asaoka, Raito and Yamashita, Hideomi and Baba, Yoshifumi},
title = {Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03087-x}
}
EUVIMED